179 related articles for article (PubMed ID: 9471801)
1. [Ceftriaxone (Rocefin) in the treatment of bronchopulmonary infections].
Nonikov VE; Konstantinova TD; Makarova OV; Manziuk EN; Minaev VI; Ritchik LA
Ter Arkh; 1997; 69(10):84-8. PubMed ID: 9471801
[TBL] [Abstract][Full Text] [Related]
2. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
McCabe RE; Schlossberg D; Donowitz GR; Scheld WM; Zellner SR; Lindenberg LB; Armstrong JH; Ein ME
Clin Ther; 1989; 11(3):304-14. PubMed ID: 2663160
[TBL] [Abstract][Full Text] [Related]
3. [A rare cause of pneumonia: Shewanella putrefaciens].
Durdu B; Durdu Y; Güleç N; Islim F; Biçer M
Mikrobiyol Bul; 2012 Jan; 46(1):117-21. PubMed ID: 22399180
[TBL] [Abstract][Full Text] [Related]
4. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
Ortiz-Ruiz G; Caballero-Lopez J; Friedland IR; Woods GL; Carides A;
Clin Infect Dis; 2002 Apr; 34(8):1076-83. PubMed ID: 11914996
[TBL] [Abstract][Full Text] [Related]
5. [Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia].
Sánchez ME; Gómez J; Gómez Vargas J; Baños V; Ruiz Gómez J; Muñoz L; Simarro E; Soto MC; Canteras M; Valdés M
Rev Esp Quimioter; 1998 Jun; 11(2):132-8. PubMed ID: 9795298
[TBL] [Abstract][Full Text] [Related]
6. [A clinical and experimental study of longatsef].
Frolov AF; Trinus EK; Rudenko AA; Diadiun ST; Antonenko SV
Vrach Delo; 1989 Oct; (10):111-3. PubMed ID: 2482583
[TBL] [Abstract][Full Text] [Related]
7. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
Gao B; Hu J; Deng W
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
[TBL] [Abstract][Full Text] [Related]
8. [A retrospective cohort study of the influence of time of hospital-acquired pneumonia onset on pathogen constitution].
Hu BJ; Wei L; Zhang XZ; Tang YC; Ni YX; Li YM; Guo JQ; Hu YJ; Zhang KX; Yang L
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):112-6. PubMed ID: 15854394
[TBL] [Abstract][Full Text] [Related]
9. [The efficacy of using the Soviet antibiotic rifamethoprim in treating acute bacterial pneumonias and chronic bronchitis].
Orlov VA; Sokolova VI; Navashin SM; Zavolovskaia LI; Manuĭlov KK
Ter Arkh; 1992; 64(3):26-9. PubMed ID: 1440269
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
11. [Cefotaxime in bronchopulmonary infections (author's transl)].
Kermarec J; Sauvaget J
Nouv Presse Med; 1981 Feb; 10(8):650-3. PubMed ID: 6259612
[TBL] [Abstract][Full Text] [Related]
12. [Effect of intratracheal administration of gentamycin in exacerbations of suppurative bronchitis due to gram-negative bacteria and Staphylococcus].
Shteĭngardt IuN; Mishustina EL; Nemerov EV
Ter Arkh; 1988; 60(3):61-4. PubMed ID: 3388275
[TBL] [Abstract][Full Text] [Related]
13. [Microbiological evaluation of differences between cephalosporins of second and third generations in general hospital].
Bogdanov MB; Chernen'kaia TV
Antibiot Khimioter; 2003; 48(1):27-30. PubMed ID: 12741320
[TBL] [Abstract][Full Text] [Related]
14. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
Querol-Ribelles JM; Tenías JM; Querol-Borrás JM; Labrador T; Nieto A; González-Granda D; Martínez I
Int J Antimicrob Agents; 2005 Jan; 25(1):75-83. PubMed ID: 15620830
[TBL] [Abstract][Full Text] [Related]
15. Cefepime/clindamycin vs. ceftriaxone/clindamycin for the empiric treatment of poisoned patients with aspiration pneumonia.
Talaie H; Jabari HR; Shadnia S; Pajouhmand A; Nava-Ocampo AA; Youssefi M
Acta Biomed; 2008 Aug; 79(2):117-22. PubMed ID: 18788506
[TBL] [Abstract][Full Text] [Related]
16. Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies.
Ortiz-Ruiz G; Vetter N; Isaacs R; Carides A; Woods GL; Friedland I
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii59-66. PubMed ID: 15150184
[TBL] [Abstract][Full Text] [Related]
17. [General and local antibiotic treatment with ceftriaxone of suppurative-septic diseases and complications].
Mariutin PV; Uchvatkin VG; Rybin EP; Grakh SI; Sokirskiĭ EK
Anesteziol Reanimatol; 1997; (3):14-8. PubMed ID: 9289978
[TBL] [Abstract][Full Text] [Related]
18. [The use of cephmetazon in treating infectious inflammatory diseases of the upper and lower urinary tract].
Derevianko II; Perepanova TS; Kotliarova GA; Kondrat'eva EM; Grishkova NV
Urol Nefrol (Mosk); 1995; (5):17-9. PubMed ID: 8571475
[TBL] [Abstract][Full Text] [Related]
19. [Clinico-bacteriological efficacy, pharmacokinetics and tolerability of netilmicin administered in a daily single dose in bronchopulmonary infections].
Salvati F; Nunziati F; Franchino L; Signora M; Portalone L; Zubiani M; Tossini G
Clin Ter; 1988 Apr; 125(1):15-24. PubMed ID: 2974354
[No Abstract] [Full Text] [Related]
20. Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy.
Katz E; Larsen LS; Fogarty CM; Hamed K; Song J; Choudhri S
J Emerg Med; 2004 Nov; 27(4):395-405. PubMed ID: 15498622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
